ursaPGx:一个新的R包,用阶段式全基因组测序数据来注释药物遗传明星等位基因
Gennaro Calendo1, Dara Kusic1, Jozef Madzo1,2
1Coriell Institute for Medical Research, Camden, NJ, United States.
Frontiers in bioinformatics
|March 27, 2024
概括
一个新的R包,ursaPGx,通过使用长时间读取的测序数据简化了药物遗传注释. 它处理分阶段的全基因组测序数据以识别明星等位基因的药物基因,增强药物反应预测.
科学领域:
- 基因组学就是基因组学.
- 药物遗传学 药物遗传学
- 生物信息学是一种生物信息学.
背景情况:
- 长读测序技术使全基因组数据的高可靠性阶段生成成为可能.
- 准确的药物遗传学注释对于个性化药物和预测药物疗效至关重要.
- 现有的工具可能无法充分利用分阶段的全基因组数据进行全面的药物基因分析.
研究的目的:
- 推出ursaPGx,一个用户友好的R包用于药物遗传学注释.
- 为了促进对多样本分阶段全基因组测序数据的分析.
- 为了自动输出恒星等位基因注释用于药物基因.
主要方法:
- 开发的ursaPGx R包. 开发的ursaPGx R包.
- 在VCF格式的多样本分阶段全基因组测序数据的输入处理.
- 与PharmVar数据库集成药物基因和明星等位基因定义.
主要成果:
- 在ursaPGx包接受阶段式全基因组测序VCF文件.
- 它准确地输出了药物基因的恒星等位基因注释.
- 该套件旨在在生物信息学管道中使用方便.
结论:
- UrsaPGx提供了一种简化的方法,用于使用长读序列数据进行药物遗传注释.
- 该工具支持对药物基因组变异进行可靠的分析.
- 它有助于通过改进基因分析来推进个性化药物治疗.
相关概念视频
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K


